Quote in 15 min·24/7 × 365AS9120:2025 · ISO 9001:2015 · FAA AC 00-56B
NSN 6505-01-362-7427CAGE 54452
11704077701
Antidote Treatment
Antidote Treatment ASAP can help source this line with documentation review, alternate part checks, condition requirements, and account manager follow-up for urgent or planned procurement.
Meridian Medical Technologies Inc
Manufacturer
USA
Origin
N/A
Spec
N/A
Unit weight
Detailed description
Technical sourcing notes
N/A
Lead time
N/A
Cross references
Unrestricted
Export control
6505 Drugs and Biologicals
FSC
Why ASAP
Operations-grade aviation sourcing.
AS9120B
Quality-managed distribution
15 min
Average RFQ response, 24/7
Full trace
Documentation & certs on request
Submit RFQ
Request a quote for 11704077701
Send this part to ASAP with quantity, need-by timing, and buyer contact details. An account manager will review availability, alternates, certificates, and delivery options.
Part-specific RFQ
Submit RFQ for 11704077701
Send this part to ASAP with quantity, need-by timing, and buyer contact details. A dedicated account manager reviews availability, alternates, certificates, and delivery options.
Antidote Treatment11704077701
NSN6505-01-362-7427
- Manufacturer
- Meridian Medical Technologies Inc
- CAGE
- 54452
Characteristics Data of NSN 6505-01-362-7427, 6505013627427
| MRC | Criteria | Characteristic |
|---|---|---|
| CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | ANTIDOTE TREATMENT NERVE AGENT AUTO INJECTOR DUAL-CHAMBER (ATNAA) |
| TEXT | GENERAL CHARACTERISTICS ITEM DESCRIPTION | AUTOINJECTOR, DUAL-CHAMBER: CONTAINING 2 MG OF ATROPINE INJECTION PER 0.7 ML, 2 ML OF PRALIODOXIME CHLORIDE INJECTION, 300 MG PER ML, AND ONE 21 GAGE STERILE NEEDLE; FOR INTRAMUSCULAR USE |
